PAPER PLAINE

Doctors could use this approach to match patients with drugs that will actually work for them before wasting months on ineffective treatment. For inflammatory bowel disease and potentially other conditions, this could spare patients unnecessary side effects and speed them toward therapies that help. The method also pinpoints which genes to target with new drugs, directly informing drug development.

Most real-world systems need to make multiple predictions at once—medical AI might diagnose disease while predicting treatment response, or autonomous vehicles must anticipate both pedestrian location and vehicle speed. Current attention methods fail under these conditions. This fix could make multi-task learning systems more reliable and generalizable, improving performance wherever models need to balance competing prediction goals.

Current brain imaging analysis might be throwing away crucial information about how cognition actually works. By capturing three-way interactions instead of just pairs, researchers can build more complete maps of brain organization, which could improve diagnosis of neurological conditions, refine understanding of how thoughts and behaviors emerge from neural activity, and provide a more accurate foundation for future brain-computer interfaces and treatments.

This work reveals that anatomy directly determines what computations neurons can perform. Because the brain's wiring can now be understood as encoding specific detection capabilities, neuroscientists can predict what kinds of signals a region of cortex can process just by measuring its physical structure. It also suggests that the brain's choice between myelinated and unmyelinated connections isn't simply about speed—it's about switching neurons between fundamentally different modes of information processing.

Depression today is usually reduced to a single score, ignoring the fact that patients suffer different symptom mixes. If AI tools can be designed to measure individual symptoms accurately and in ways doctors understand, they could help clinicians spot which patients need which treatments. This work shows it's possible to build depression-screening tools that are both powerful and transparent about how they reach their conclusions, potentially making AI more trustworthy in mental health care.

Drug discovery relies on predicting how experimental molecules will bind their targets before expensive testing begins. This work exposes a critical gap: most peptide-binding models are benchmarked in unrealistic conditions and would fail in the real world, where researchers must predict binding to new disease targets they've never seen before. The findings demand that future benchmarks test what actually matters—whether methods can handle unfamiliar targets—and reveal which representation strategies hold up under that harder test.

Most neuromorphic chips today are engineered around spike-based computation, which doesn't match how many brain-inspired models actually work. This research expands what problems neuromorphic hardware can solve efficiently, potentially unlocking its use for broader classes of neuroscience simulations and AI applications that currently require conventional computers. For researchers running large-scale brain simulations, this could mean significantly lower power consumption.

Understanding how biological and engineered networks waste energy matters for designing efficient systems — from neural circuits to chemical reactions to supply chains. This work reveals that the efficiency loss follows a predictable formula across radically different system types, which could help engineers set realistic performance targets and predict where to intervene to reduce waste.

Brain-computer interfaces and neuroscience studies often have access to limited recordings, making current methods impractical. This model cuts the data needed for reliable decoding by a substantial margin, which could accelerate research into how the motor cortex controls movement and speed up development of prosthetics and rehabilitation tools that depend on accurately reading neural signals.

This work bridges neuroscience and artificial intelligence by showing that aesthetic pleasure may be rooted in processing efficiency rather than arbitrary cultural preferences. Understanding what makes faces attractive has applications in facial recognition systems, cosmetic surgery planning, and media design — and suggests that beauty judgments might be partly universal rather than entirely learned.

As AI takes on more scientific work, bad analysis can become invisible: an agent might selectively report favorable results, declare success too early, or optimize for a flawed measure—all without a scientist noticing. Brain Researcher catches these problems before they become published claims by embedding scientific judgment into the workflow itself, not as an afterthought. This matters for neuroimaging and beyond: it's the difference between an AI assistant that sounds confident and one that actually produces defensible science.

This is a step toward brain-computer interfaces that could help people who cannot speak or move — eventually allowing them to communicate their thoughts directly. The finding that the method kept improving with more data suggests that with denser recordings or better technology, we might eventually decode thoughts with practical accuracy. Understanding which brain signals carry word meaning also reveals how the brain processes language silently.

Cell biologists rely on these visualizations to understand which cell types are common, which are rare, and which represent transitions between states — critical for discovering new cell populations and understanding disease progression. Distorted density patterns have led researchers to misidentify the prevalence of rare cells, potentially steering biological discovery in the wrong direction. DMT-Dens lets biologists see the true distribution of their samples, making it easier to catch genuinely rare events and understand the actual landscape of cell diversity.

Current mathematical models of neural networks often treat incoming signals as interchangeable if their total strength converges properly. This work shows that assumption breaks down for threshold-based neurons: the timing order of excitation versus inhibition fundamentally changes the network's behavior. Understanding this could improve how neuroscientists and engineers predict neural circuit responses and design more accurate models of brain computation.

These findings reveal how AI systems make decisions when faced with competing demands, which matters for predicting when they'll follow explicit instructions reliably versus reverting to patterns baked into their training. Understanding this conflict mechanism could improve how we design prompts and fine-tune models to follow rules even when they contradict the model's default behavior—important for safety and reliability in high-stakes applications.

For centuries, philosophers have had no systematic way to even discuss whether another person's experience resembles yours. These structural approaches create a shared framework where different minds can be meaningfully compared, which matters for everything from diagnosing consciousness in patients who can't communicate, to assessing animal sentience, to eventually building AI systems whose experiences we might actually understand rather than merely observe.

Neuroscientists have proposed multiple mechanisms for how the brain might encode information in oscillating signals—from electromagnetic fields to quantum effects in microtubules. This test provides a single, mechanism-independent standard to rule out implausible candidates before investing time and resources studying them. It eliminates most high-frequency proposals immediately, while showing that only the brain's low-frequency rhythms have the spectral sharpness needed to reliably carry multiple distinct signals.

Brain disorder diagnosis currently requires pooling data from multiple hospitals—but sharing raw scans raises privacy concerns. FedDOSE lets hospitals train AI models together on their local data without sending scans elsewhere, while still achieving better diagnostic accuracy. This could accelerate research into neurodevelopmental disorders without compromising patient privacy.

Drug development costs billions and takes over a decade. If companies could identify failing programs earlier using historical evidence patterns, they could redirect resources to candidates with better odds of reaching patients. This tool lets sponsors test whether their judgment call was sound given what was actually known at the time—and might help prevent another 40–50% of Phase II failures tied to weak target-disease links.

This framework could guide the design of therapies and care routines by treating them as optimization problems—essentially ways to gradually expand what someone finds familiar and predictable rather than forcing adaptation to unpredictability. It also offers a way to quantify and communicate difficult experiences like sensory overload and anxiety in autistic individuals, potentially helping caregivers and support programs respond more effectively to actual needs rather than guesswork.

For neuroscience, this means that choosing which brain regions to stimulate or target therapeutically affects not just how much energy is needed, but which brain states become reachable. Two interventions might cost the same overall but produce different outcomes—suggesting that existing energy-based calculations miss important information when designing treatments for neurological conditions or brain stimulation therapies.

Neuroscientists spend months collecting expensive neural recordings to test competing models of how the brain works. This framework lets them know upfront whether a model improvement is large enough to matter—for instance, whether they need 120 milliseconds or 11 seconds of additional recording to confidently reject a simpler baseline model. That clarity helps researchers allocate limited recording time efficiently and judge whether their hard-won data actually supports their scientific claims.

Understanding what LLMs and human cognition genuinely have in common could improve how we design, test, and predict the behavior of AI systems. It also helps us move past the assumption that AI intelligence is fundamentally alien, which has blocked clearer thinking about what these systems can and cannot do. This framework could guide better questions about when we should and shouldn't trust AI reasoning.

Understanding how organisms actually navigate could improve robot design, from search-and-rescue drones to autonomous vehicles that need to find targets in unfamiliar environments. The framework also reveals what makes each creature's strategy work — why a bacterium tumbles the way it does, or how a fruit fly learned to track smells — which could lead to better biological pest control or faster algorithms for AI agents learning to explore.

IDyOM is the standard tool for testing theories about how humans anticipate music, but its technical barriers meant most researchers couldn't easily modify or integrate it into their own work. GraphIDyOM removes those barriers, potentially accelerating research into musical cognition, improving music recommendation systems, and enabling new interactive applications that respond to listener expectations in real time.

Brain-computer interface companies currently need to build separate personalization pipelines for each model they want to support. A universal adapter means they can integrate once and swap between models freely as technology improves, cutting engineering complexity and time-to-market. For users, faster calibration means less time in the setup chair before the system is ready to use.

Brain shape changes can signal disease progression or neurological decline, but current tools struggle to connect these changes to multiple patient factors simultaneously. This method handles the messy reality of medical data — some measurements come as numbers, others as images — making it possible to untangle which factors actually drive shape changes in conditions like Alzheimer's disease. That clarity could help clinicians spot early warning signs and design better targeted interventions.

Understanding how brains maintain focus on a single goal—without needing neurons to fight it out competitively—reveals a simpler design principle that evolution has used more than once, in flies' compass circuits and in their learning centers. This could reshape how neuroscientists think about goal-directed behavior and inform designs for artificial systems that need to track and maintain a stable target direction.

The ventral visual stream (object recognition) is already well-understood through similar datasets and neural models, but the dorsal stream (motion and spatial awareness) has lagged behind because neuroscientists lacked comparable data. STSBench closes that gap, allowing researchers to finally build and test theories about how brains encode motion and spatial navigation—work that could illuminate both healthy vision and how these processes break down in disease, and potentially improve artificial vision systems designed to interpret movement and space.

Brain circuit mapping is currently so slow and damaging that scientists can only map tiny pieces of neural tissue. This method could enable much larger connectome maps in living animals, accelerating research into how neural circuits produce behavior and disease. Faster experiments also mean researchers can study more animals and conditions with the same resources.

Understanding how networks restart from silent states could explain how brains maintain working memory and switch between different mental states without continuous neural chatter. The ability to predict network behavior from a snapshot of synaptic state, rather than watching the full dynamics unfold, offers a faster way to diagnose and potentially intervene in disorders where abnormal firing patterns emerge from hidden synaptic changes.

Systems that adapt to humans—from rehabilitation robots to training software—currently either treat people as mysterious inputs-to-outputs or sacrifice mathematical rigor for interpretability. This framework does both: it lets engineers see *why* someone is making a choice (not just predict what they'll do) and gives them equations they can actually control. That means building assistive devices that adjust in real time based on what someone is actually thinking, not just what they're doing.

Drug companies rely on these AI models to screen millions of candidate molecules quickly. If models fail silently on unusual chemical structures, they could miss effective drugs or recommend dangerous compounds. This work reveals that current evaluation practices mask real weaknesses, meaning companies need better testing protocols before deploying these tools in actual drug discovery pipelines.

Current drug discovery AI tools ignore disease context, potentially missing how the same protein behaves differently across conditions. DrugGen-2 bridges this gap, which could speed up finding treatments for complex diseases where target proteins change behavior. This matters because it compresses a lengthy trial-and-error process—generating better drug candidates faster could accelerate development for conditions like diabetic nephropathy where current treatments remain suboptimal.

Most AI tools hit a wall when asked to work on research that stretches over weeks or months—they can't remember what they've already done and decisions get worse as context piles up. This system stays reliable across long projects by strategically forgetting completed work, meaning it could accelerate drug development and other multi-month computational research without human hand-holding or rebuilding the entire conversation each week.

Most genetic disease prediction fails in real clinical settings because training data is scarce and imbalanced—healthy people vastly outnumber sick ones. This method addresses both problems by leveraging what we already know about how genes interact, meaning hospitals could make more reliable predictions from smaller patient groups. The built-in confidence scores also help clinicians avoid false alarms and know when a result is unreliable.

Neuroscientists use these artificial networks to understand how real brains process information by comparing network behavior to actual brain recordings. Without knowing how these networks truly distribute activity across their components, researchers can't tell whether their models actually capture real brain dynamics or just produce superficially similar results. This work provides the missing mathematical foundation to make those comparisons meaningful.

Current AI models that analyze medical images can't reliably explain which biological features they're actually detecting because multiple concepts get tangled together in their compressed representations. This method lets researchers cross-validate what AI systems learn from patient images against actual molecular data, creating a foundation for AI-driven spatial biology that doesn't require expensive reference samples—potentially accelerating discovery of disease mechanisms in neurodegenerative conditions.

Before deploying AI in medical settings, hospitals need to know whether a model reached the right diagnosis through sound clinical logic or lucky pattern-matching. This work shows that accuracy scores alone hide a deeper problem—AI systems can be right for the wrong reasons, which matters enormously for trust and safety. The researchers released their analytical tools so that hospitals and regulators can now examine how an AI actually reasons, not just whether it guesses correctly.

This principle could explain how real-world systems from cells to ecosystems to economies organize themselves without anyone in charge. Understanding these ground-level rules might help us design more resilient networks, predict how biological systems evolve, or troubleshoot why some organizations thrive while others stagnate.

Materials scientists often can't directly measure the fundamental properties that control how materials separate and form patterns, but need to know them to design alloys, polymers, and other engineered materials. This method cuts the number of observations needed to infer those hidden rules, potentially speeding up materials discovery and making it cheaper to characterize new substances without running expensive, lengthy experiments.

Brain-computer interfaces aim to help people with paralysis or locked-in syndrome control prosthetics or communication devices. If one decoding method worked best for everyone, clinical deployment would be straightforward. This work shows that practical BCI systems need to personalize their approach for each user rather than relying on a single universal design, suggesting that real-world BCI performance depends as much on fitting the algorithm to individual brain differences as on the algorithm itself.

Public health officials use contact tracing to understand outbreak dynamics, but existing tools struggle to extract transmission rates from incomplete records. This framework turns messy contact-tracing data into precise estimates of who is most likely to spread disease and how many contacts matter, enabling faster identification of superspreaders and better targeting of interventions during future outbreaks.

Healthcare providers in rural or under-resourced areas often lack specialists to review complex cases. A system that can systematically extract and connect evidence across all available patient data, then decide whether a case needs referral to a tertiary hospital, could reduce delays in care and improve triage accuracy. The framework's built-in uncertainty checking also prevents overconfident recommendations that might lead clinicians astray.

Type 1 diabetes patients rely on accurate glucose forecasts to manage their insulin delivery and prevent dangerous blood sugar swings. Until now, researchers have compared forecasting algorithms using different datasets and methods, making it impossible to tell which approaches actually work best. MetaboNet-Bench gives the research community a shared standard, enabling faster innovation and clearer identification of which data sources matter most for better predictions.

Protein generation AI could accelerate drug discovery and enzyme design, but scientists can only trust these models once they understand what the AI is actually doing. By making these models interpretable, researchers can verify the generated proteins follow real biological principles, catch failures before expensive lab testing, and potentially steer the AI toward specific desired properties—turning black-box generation into a tool biologists can actually use.

Biological experiments are expensive and produce limited data points, so extracting reliable mechanistic rules from them is critical for everything from disease modeling to drug design. Most current AI approaches assume all noise looks the same, which often misses real biological complexity and leads to wrong predictions. This framework lets researchers automatically discover what kind of variability they're actually dealing with, improving confidence in conclusions drawn from small, expensive datasets.

Hospitals, health insurers, and public health agencies currently can't afford to use the most powerful AI models for fact-checking medical claims at scale. This work shows they can deploy smaller, cheaper models instead—without sacrificing accuracy and while actually improving reliability across different types of medical information. That means institutions with modest budgets can now automate detection of medical misinformation that spreads online or within their own systems.

Understanding how brains organize information could lead to better artificial memory systems for AI — and might explain why animals can reliably store and recall vast amounts of spatial information despite the brain's physical limits. If we can replicate this hyperbolic geometry in machine learning models, we could build systems that remember more while using less computational power.

EEG-based AI models are moving into clinical use for diagnosing epilepsy, sleep disorders, and brain injuries, where misplaced confidence in false accuracy could harm patients. Without tools like FMScope, hospitals might deploy models that perform well on test data but fail on new patients they've never seen—because the model learned to recognize individual brains rather than disease patterns. This work provides a concrete method to audit foundation models before clinical deployment and shows which features are genuinely tied to disease versus which are diagnostic dead ends.

Early psychosis is notoriously hard to diagnose reliably in its earliest stages, when intervention could make the biggest difference. A measurable shift in how the brain organizes itself across multiple time scales could eventually become a more objective marker of early psychosis, complementing clinical interviews and helping clinicians identify at-risk individuals sooner. The framework used here—combining multiple scaling measures—also provides psychiatry with a more robust toolkit for understanding whether other mental health conditions involve loss of critical dynamics or reorganization within them.

This work bridges artificial intelligence and neuroscience, showing that speech AI systems can serve as testbeds for understanding how the human brain processes language. The findings could accelerate research into speech disorders, improve brain-computer interfaces for people with paralysis, and guide the design of AI systems that process language more like humans do.

Drug regulators and safety teams currently rely on computational models to catch rare side effects before they harm patients. This research shows those models have a hard ceiling—knowing a drug's molecular structure isn't enough. Understanding where that ceiling is lets regulators know when they need additional testing, human expertise, or real-world monitoring instead of trusting predictions that might miss real dangers.

This finding bridges a major gap between how AI language models work and how human brains process language. It shows that the brain's semantic architecture isn't arbitrary—it emerges naturally when systems learn to understand language—which could help neuroscientists understand language processing and AI researchers build models that align more closely with biological intelligence.

Understanding which principles are shared across primate brains helps neuroscientists and AI researchers build better models of vision. The finding that early visual processing is robust and rule-agnostic suggests this is a fundamental principle worth mimicking in artificial systems, while the brittleness of higher visual areas points to practical limits: you can't match complex visual reasoning by tweaking learning algorithms alone—you need better training data and larger networks.

Brain-computer interfaces that help paralyzed patients control prosthetics or communicate depend on fast, accurate decoding of brain signals—every millisecond and every electrode matters. By cutting through noise automatically and improving accuracy, BCI-sift could make these systems more reliable and easier for engineers to develop, ultimately delivering faster response times and more intuitive control to users who need it most.

Proteins fold into thousands of distinct shapes, and each shape determines what the protein does in living cells. Faster, cheaper ways to classify these folds could accelerate drug discovery, help predict how mutations affect disease, and make protein research accessible to labs without massive computing budgets. The openly shared benchmark also gives the field a common standard for measuring progress.

Brain activity emerges from billions of neurons firing in complex patterns, and understanding what drives these patterns is central to neuroscience. This work explains why the same stimulus can produce different collective firing patterns depending on recent neural history—a finding that could improve how researchers interpret experimental recordings and build more realistic computational models of brain circuits.

Brain-computer interfaces need both prediction and readout, usually requiring separate models and extra computational overhead. This approach cuts that complexity in half while running fast enough for real-time closed-loop experiments on standard lab computers, making it practical for researchers developing neural prosthetics or studying decision-making in animal models.

Brain-enhanced AI could eventually improve medical diagnosis systems, brain-computer interfaces, and neuroscience research tools. But collecting brain scans is expensive and time-consuming, so knowing in advance whether it will actually help — rather than wasting resources on data that won't improve the model — matters for smart research planning.

Understanding how embryonic cell cycles are controlled could reveal what goes wrong in birth defects or cancer, where timing and coordination break down. Since fruit flies share many of the same molecular machines that control human cell division, insights from this model offer a bridge between simple mathematical rules and the complex biology of early development.

Nerve injuries from stroke or spinal cord damage are hard to assess — doctors can't easily tell if healing is happening without invasive procedures. Being able to track recovery with simple electrical readings from skin electrodes would let clinicians adjust treatment earlier, predict which patients will recover function, and measure whether new therapies actually work. This bridges the gap between understanding what's happening at the molecular level and knowing whether patients are actually getting better.

Supercooled liquids (water that's frozen solid in temperature but still liquid in structure) have real uses in cryopreservation and medical storage. Understanding how to keep them stable longer without chemical additives could improve organ transplant viability and reduce biological sample damage during freezing procedures.

Scientists can now study how babies develop motor skills by literally experiencing movement through a robot's sensors, rather than just watching from the outside. This opens new ways to detect early signs of developmental disorders, helps roboticists design machines that learn more like humans do, and gives developmental psychologists direct access to the sensory world of infancy—something previously impossible to measure or replicate.

Current brain imaging methods often place neural activity in the wrong location or require oversimplified assumptions about how the brain is organized. This approach leverages individual brain anatomy to make non-invasive scans more precise, which could improve diagnosis of conditions like epilepsy and strengthen neuroscience research by capturing faster, more detailed maps of how different brain regions communicate.

As people increasingly turn to chatbots for mental health guidance, this gap matters in opposite ways: the systems are reliable safety nets that won't let genuine crises slip through unnoticed, but they may also overwhelm emergency services and create unnecessary anxiety by treating normal distress as a crisis. Better calibration could preserve the protective function while reducing false alarms.

Brain imaging studies often struggle because each person's brain is wired slightly differently, making it hard to draw general conclusions. This method cuts through that noise to identify which brain networks actually respond to language, regardless of where those networks sit in each individual's head. That makes it easier for neuroscientists to compare results across studies and build more accurate models of how we understand language and stories.